Learn
News
Veterinarian Tarkan Özçetin Discusses Specialized Feline Care in New Greycoat Research Interview
Greycoat Research shares a new interview video featuring Dr. Tarkan Özçetin on specialized feline care and long-term kidney support.
Greycoat Research Strengthens Clinical R&D Through Strategic Advisory Partnership in Japan
Greycoat Research has entered into an advisory partnership with Kobayashi Animal Hospital in Japan to strengthen its research and clinical advisory network in feline kidney health.The collaboration supports Greycoat Research’s broader research-driven strategy through international scientific exchange, clinical insight, and long-term academic collaboration.
Greycoat Research Enters Turkey with 3-Year Exclusive Feline Kidney Health Partnership
Greycoat Research has entered the Turkish market through a three-year exclusive agreement with Felikan Farma, expanding its veterinary distribution network for feline kidney health support.
New Launch: Low Protein Salmon Treat for CKD Cats
Greycoat Low Protein Salmon was created to offer cats with kidney concerns a gentler treat option that supports enjoyable feeding without adding unnecessary dietary burden.By pairing low-protein ingredients with careful portion design, it provides a simple way for guardians to share positive moments with their cats while staying mindful of overall nutritional balance.
Direct U.S. Shipping Begins September 30 – Limited Availability
Greycoat Research will begin limited direct U.S. shipping on September 30, 2025, offering faster delivery for up to 100 items.This marks an early step toward our full U.S. and global launch planned for 2026.
Japan Launches First Nationwide Trial of AIM-Based Kidney Drug for Cats
The AIM-based feline kidney treatment is currently undergoing clinical trials in Japan and has not yet received approval.Greycoat Research will continue to share updates on AIM research while supporting guardians with non-medical, management-focused supplements.